Medindia9 小时
Alphyn Granted U.S. Patent Covering First-in-Class Treatment for Atopic Dermatitis
Patent covers compositions and methods of use of drug formulation for Zabalafin Hydrogel ANNAPOLIS, Md., Dec. 10, 2024 /PRNewswire/ --  Alphyn, a clinical-stage dermatology company developing first-in ...
‘My Chronic Hives Were Dismissed by Doctors for Years—Here’s How I Finally Got a ...
Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...